The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study

C Fordham von Reyn1, R D Arbeit, A N Tosteson

  • 1Infectious Disease Section, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.

AIDS (London, England)
|August 1, 1996
PubMed
Abstract

Insights

Disseminated Mycobacterium avium complex (MAC) infection is more common in developed countries among AIDS patients. Differences in exposure and immunity contribute to these higher rates, suggesting prevention strategies.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Disseminated Mycobacterium avium complex (MAC) infection poses a significant threat to individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • Understanding geographical variations in MAC infection rates is crucial for developing targeted public health interventions.
  • Factors influencing MAC susceptibility, including environmental exposure and immune status, require further investigation.

Purpose of the Study:

  • To compare the incidence of disseminated MAC infections in AIDS patients across developed and developing nations.
  • To investigate whether disparities in infection rates are attributable to differences in environmental exposure or host immunity.
  • To identify specific risk factors associated with disseminated MAC in immunocompromised individuals.

Main Methods:

  • A prospective cohort study was conducted involving 566 HIV-infected subjects with CD4 counts below 200 cells/µL.
  • Data collection included interviews, CD4 lymphocyte counts, mycobacterial blood cultures, and skin testing with purified protein derivative (PPD) and M. avium sensitin.
  • Statistical analysis, including multiple logistic regression, was employed to identify risk factors for disseminated MAC.

Main Results:

  • Disseminated MAC rates were significantly higher in developed countries (10.5-21.6%) compared to developing countries (2.4-2.6%).
  • A higher prevalence of positive PPD skin tests was observed in patients from Kenya (20%) versus other sites (1%).
  • Risk factors for disseminated MAC included low CD4 count, indoor pool swimming, bronchoscopy history, raw/partially cooked fish/shellfish consumption, and G-CSF treatment; occupational soil/water exposure showed a protective effect.

Conclusions:

  • Higher rates of disseminated MAC in AIDS patients from developed countries are linked to both increased exposure and altered immunity.
  • The findings support the development of preventive strategies, including active immunization and measures to reduce environmental exposure to MAC.
  • Further research into the interplay of exposure, immunity, and MAC infection is warranted.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...